Sand Hill Angels

Sand Hill Angels is one of Silicon Valley's oldest angel investment groups, formed more than 25 years ago near the legendary Sand Hill Road venture capital corridor. With 145+ active angel members, the group has spent over two decades backing early-stage companies across deep technology, life sciences, enterprise software, and emerging tech sectors. Understanding NRR and why top quartile exceeds 120% is valuable for any founder.

Unlike a traditional VC firm with a small partnership, Sand Hill Angels is a member-driven consortium of experienced entrepreneurs and executives who invest their own capital alongside operational mentorship. Many members have founded, built, and exited companies before turning to angel investing. This gives the group a perspective that institutional venture funds cannot replicate.

The organization's investment thesis centers on identifying disruptive, scalable technologies with the potential to build profitable businesses. Sand Hill Angels explicitly seeks companies that value patient capital over rapid-fire growth at any cost, preferring founders who are building sustainable businesses rather than chasing the latest venture trends.

What sets Sand Hill Angels apart is the two-step pitch process designed to give both sides meaningful engagement. Startups first present to the full membership on the last Thursday of the month. If advanced, they move to a second 35-minute deep-dive session with Q&A before any investment commitment is made. This structure reflects the group's belief that angel investing works best when investors truly understand what they are backing.

For founders seeking capital, Sand Hill Angels represents an opportunity to access not just checks but decades of accumulated experience. The group's members have collectively witnessed every cycle in Silicon Valley, and that institutional knowledge gets passed to portfolio companies in ways that pure financial investors cannot replicate.

Sand Hill Angels invests in companies that are building disruptive, scalable technologies targeting large and growing markets. The group explicitly values profitable business building over pure growth-at-all-costs mentality, which shapes both the types of founders they back and their expectations around unit economics. Understanding unit economics and LTV:CAC is valuable for any founder.

Sector focus spans enterprise software, SaaS, mobile applications, cloud infrastructure, life sciences, biotech, clean tech, and emerging technologies. The group has shown particular interest in companies with defensible technology moats—whether proprietary IP, unique data assets, or novel technical approaches that are difficult to replicate.

Unlike pure seed-stage investors, Sand Hill Angels participates across a wider stage range. Their typical engagement begins at seed, but the group is comfortable investing through Series B when a company's trajectory warrants additional capital. This flexibility allows the group to follow winners and avoid the pressure of having to exit at a specific timeline.

The investment thesis also reflects a preference for patient capital. Sand Hill Angels members are not forced by fund timelines to exit within a prescribed window. This patient stance means founders can focus on building durable businesses rather than manipulating metrics toward an artificial exit on someone else's schedule.

Beyond the financial investment, Sand Hill Angels provides portfolio companies with access to their deep network of industry executives, potential customers, and follow-on investors. The group has built these relationships over 25 years, and leveraging that network effectively is a key component of what the group offers beyond capital alone.

Founders who align with Sand Hill Angels's thesis typically demonstrate clarity around their business model, a realistic view of their competitive landscape, and an understanding of the path to profitability. The group is skeptical of pitch decks heavy on TAM projections and light on evidence of product-market fit.

Sand Hill Angels evaluates investments across seven core dimensions: quality of management, market opportunity, product concept, competition, go-to-market plan, financial projections, and potential returns. No single dimension outweighs the others—a balanced assessment across all seven is typically required for a successful outcome. Understanding healthcare financial benchmarks is valuable for any founder.

Quality of management sits at the top of the evaluation hierarchy. The group looks for founders with deep domain expertise, a clear vision for the company, and the ability to attract and retain talent. Importantly, Sand Hill Angels members have been founders themselves, so they evaluate founder quality with direct experiential understanding of what separates capable operators from those who are new to building companies.

Market opportunity must be large and growing, with a well-defined problem that the company is solving. Sand Hill Angels is not interested in creating markets; they prefer founders who are attacking existing large markets with a differentiated solution that can capture meaningful share.

Product concept must demonstrate clear differentiation from existing solutions and show evidence of product-market fit. For early-stage companies with limited historical data, the group looks for meaningful customer engagement metrics, strong user feedback, or early revenue signals that indicate the product resonates with buyers.

Competitive positioning receives careful scrutiny. Sand Hill Angels looks for companies with defensible advantages—whether through proprietary technology, exclusive partnerships, brand recognition, or network effects—that can protect market position over time. Founders who cannot articulate their competitive moat clearly will struggle in the evaluation process.

Financial projections should be realistic and grounded in evidence. Sand Hill Angels will challenge assumptions and push founders on the basis for their forecasts. Be prepared to explain the data underlying your projections and demonstrate that you have considered multiple scenarios.

The group's evaluation criteria are not a checklist—they are applied holistically by Special Interest Groups (SIGs) who review companies monthly before any recommendation to the broader screening committee.

Sand Hill Angels maintains an active investment pace, deploying capital across multiple sectors and stages throughout the year. The group's most recent verified investments include ImmuneBridge, a cell therapy manufacturing company that raised a $7.7 million seed extension to expand its allogeneic immunotherapy platform. This investment reflects the group's continued interest in life sciences and advanced therapeutics.

The group also participated in Mythical Games' ongoing round—a blockchain gaming company building player-owned economies with a video game engine approach. The investment demonstrated Sand Hill Angels's appetite for companies at the intersection of gaming, blockchain technology, and new economic models.

Across 2023 and 2024, the portfolio has included companies spanning biotech (Nanocan Therapeutics, GigaMune, AltrixBio), enterprise software (Dasera, a data governance and security platform), clean tech (DroneSeed using heavy-lift drone swarms for reforestation), and infrastructure (Aerolane building same-day ground logistics at shipping costs).

The 2025 and 2026 portfolio activity shows continued focus on deep technology and life sciences, with investments in companies like Lovu Health (Series A) and TrueMeter (financial software). The group maintains a pipeline that reflects both core competencies and emerging areas where member expertise creates an information advantage.

Quarterly update requirements for portfolio companies mean that active communication with the group is part of the post-investment relationship. This ongoing engagement allows Sand Hill Angels to provide targeted guidance and, where appropriate, facilitate introductions or follow-on investment discussions.

Sand Hill Angels has also adapted its investment process for changing market conditions, implementing more comprehensive due diligence while maintaining the accessibility that makes the group attractive to founders who might not yet have access to top-tier institutional VC.

Sand Hill Angels has backed companies that have reached significant scale, with 9 unicorn investments and 16 confirmed exits over the group's history. The portfolio spans sectors reflecting the breadth of Silicon Valley's innovation ecosystem.

In life sciences, ImmuneBridge is developing allogeneic immunotherapies for cancer, leveraging a proprietary cell therapy manufacturing platform. Nanocan Therapeutics provides medicines for patients with certain cancers and respiratory tract infections. GigaMune focuses on T cell therapeutics for solid tumors, and AltrixBio is building oral drugs that replicate the metabolic success of bariatric surgery.

In enterprise software and infrastructure, Dasera offers a DataGovOps platform protecting data throughout its lifecycle by enforcing governance policies. TrueMeter operates in the financial software sector, and multiple portfolio companies address cloud computing, mobile, and SaaS infrastructure.

Consumer and vertical markets are represented by companies like McMullen Mgmt building the next major e-commerce fashion brand focused on diverse designers, and Sellhound operating a price comparison engine for secondhand marketplaces. Fitnescity is building the world's largest platform of wellness tests.

Deep tech and hardware include Matrix Industries, a pioneer of self-powered machine-learning solutions for connected devices, and Vantage Robotics making aerial video easy for commercial operations. mmTron is a leading provider of 5G mmwave linear power-efficient broadband products for wireless communications.

Clean tech and sustainability investments include DroneSeed (reforestation using heavy-lift drone swarms to plant seed vessels after wildfires), GaeaStar (developing geo-neutral products through manufacturing), and OXOS Medical (digital imaging devices for patient treatment).

Sand Hill Angels accepts funding applications year-round through their Dealum platform. Applications that are incomplete typically get rejected without review, so founders should invest the time to submit a thorough application. The platform is the primary intake channel and the starting point for all new submissions.

Beyond the formal application, warm introductions from existing portfolio founders, other trusted investors, or respected members of the Silicon Valley community remain the most effective path to securing a meeting. Building relationships with individual Sand Hill Angels members before submitting a formal application significantly improves your chances of being noticed.

Sand Hill Angels members also host a RAW program that provides pitch practice and real-time investor feedback in a low-pressure environment. While RAW is explicitly for pitch practice and not funding, it offers an opportunity to refine your pitch in front of experienced angels and build relationships before the formal application process.

The investment process follows a structured two-stage format. After passing the initial screening, founders present a 10-minute pitch followed by 5 minutes of Q&A at the monthly full-membership meeting on the last Thursday of the month. If advanced, companies move to a second pitch approximately two weeks later—a 35-minute deep-dive session with detailed diligence questions.

Following a positive second pitch, investment terms are negotiated and the process moves toward closing. Post-investment, Sand Hill Angels requires quarterly updates from portfolio companies, maintaining an active relationship designed to provide ongoing value beyond the initial check.

When preparing your application, focus on clarity around the problem you are solving, your differentiated solution, the market opportunity, your team's relevant experience, and your path to revenue. Sand Hill Angels values directness—members have seen thousands of pitches and can identify hype quickly.

While Sand Hill Angels invests across a wider stage range than many angel groups, they still expect founders to have a solid command of their financials. This includes understanding burn rate, runway, unit economics, and a realistic path to profitability or the next equity round.

Founders should be prepared to discuss their business model in depth, including pricing strategy, customer acquisition costs, and lifetime value calculations. Early-stage companies without extensive revenue should come with clear evidence of customer traction—meaningful engagement metrics, strong user feedback, or early revenue signals that indicate product-market fit.

Financial projections should be grounded in evidence, not optimistic TAM calculations. Sand Hill Angels will challenge projections and ask founders to explain the basis for their assumptions. Be ready to walk through multiple scenarios and demonstrate that you have stress-tested your business model.

Understanding your key performance indicators is essential. Sand Hill Angels will want to see that you track the metrics that matter most to your specific business and can explain trends in your performance data coherently.

Many first-time founders underestimate the importance of financial preparedness when approaching angel investors. Investors want to see that founders understand the financial mechanics of their business and have realistic expectations for how capital will be deployed.

Working with a fractional CFO can meaningfully improve your chances of securing funding. Professional financial guidance helps you build accurate projections, prepare investor-ready financials, and confidently navigate due diligence questions. For early-stage companies preparing to pitch Sand Hill Angels, having professional-quality financials signals operational maturity that differentiates you from the competition.